Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 7, 2011, Pages 624-627

  Zheng, Xing Wu ^a,c   Kudaravalli, Rama ^a,c   Russell, Theresa T ^b,c   Dimichele, Donna M ^d   Gibb, Constance ^d   Russell, J Eric ^b,c   Margaritis, Paris ^b,c   Pollak, Eleanor S ^a,b,c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

chromatin immunoprecipitation; factor VII deficiency; hemophilia B Leyden; hepatocyte nuclear factor 4

Indexed keywords

BLOOD CLOTTING FACTOR 7; HEPATOCYTE NUCLEAR FACTOR 4ALPHA;

ADOLESCENT; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; IMMUNOPRECIPITATION; LABORATORY TEST; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD;

ADULT; BASE SEQUENCE; BINDING SITES; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FACTOR VII; FACTOR VII DEFICIENCY; HELA CELLS; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; IMMUNOPRECIPITATION; LONGITUDINAL STUDIES; MALE; PLASMIDS; POINT MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; TRANSFECTION; TWINS, DIZYGOTIC;

EID: 80053617355     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e3283497699     Document Type: Article

References (23)

1. Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood 1983; 62:784-791. (Pubitemid 13008666)
2. Perry DJ. Factor VII deficiency. Blood Coagul Fibrinolysis 2003; 14 (Suppl 1):S47-54. (Pubitemid 36951884)
3. Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5'-flanking region. J Biol Chem 1996; 271:1738-1747.
4. Greenberg D, Miao C, Ho W, Chung D, Davie E. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 1995; 92:12347-12351. (Pubitemid 26014067)
5. Erdmann D, Heim J. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 1995; 270:22988-22996.
6. Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood 1997; 89:176-182. (Pubitemid 26428191)
7. Kavlie A, Hiltunen L, Rasi V, Prydz H. Two novel mutations in the human coagulation factor VII promoter. Thromb Haemost 2003; 90:194-205. (Pubitemid 36992496)
8. Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood 1998; 92:1639-1645. (Pubitemid 28406867)
9. Carew JA, Pollak ES, Lopaciuk S, Bauer KA. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency. Blood 2000; 96:4370-4372.
10. Ellrott K, Yang C, Sladek FM, Jiang T. Identifying transcription factor binding sites through Markov chain optimization. Bioinformatics 2002; 18 (Suppl 2):S100-109. (Pubitemid 41073224)
11. Reitsma PH, Bertina RM, Ploos van Amstel JK, Riemens A, Briet E. The putative factor IX gene promoter in hemophilia B Leyden. Blood 1988; 72:1074-1076.
12. Hung HL, Pollak ES, Kudaravalli RD, Arruda V, Chu K, High KA. Regulation of human coagulation factor X gene expression by GATA-4 and the Sp family of transcription factors. Blood 2001; 97:946-951. (Pubitemid 32154278)
13. Crossley M, Brownlee GG. Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature 1990; 345:444-446.
14. Crossley M, Ludwig M, Stowell KM, De Vos P, Olek K, Brownlee GG. Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter. Science 1992; 257:377-379.
15. Boyd KE, Farnham PJ. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol Cell Biol 1999; 19:8393-8399. (Pubitemid 30414033)
16. Pollak ES, Russell TT, Ptashkin B, Smith-Whitley K, Camire RM, Bauer KA. Asymptomatic factor VII deficiency in African Americans. Am J Clin Pathol 2006; 126:128-132. (Pubitemid 44025081)
17. Mariani G, Herrmann FH, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7). Blood 2000; 96:374. (Pubitemid 30456500)
18. Herrmann FH, WulffK, Auerswald G, SchulmanS, AstermarkJ, Batorova A, et al. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009; 15:267-280.
19. Bernardi F, Dolce A, Pinotti M, Shapiro AD, Santagostino E, Peyvandi F, et al. Major differences in bleeding symptoms between factor VII deficiency and hemophilia B. J Thromb Haemost 2009; 7:774-779.
20. Mota L, Shetty S, Idicula-Thomas S, Ghosh K. Phenotypic and genotypic characterization of factor VII deficiency patients from western India. Clin Chim Acta 2009; 409:106-111.
21. Reijnen MJ, Peerlinck K, Maasdam D, Bertina RM, Reitsma PH. Hemophilia B Leyden: substitution of thymine for guanine at position-21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoter. Blood 1993; 82:151-158. (Pubitemid 23188759)
22. Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vasc Biol 1996; 16:1170-1176. (Pubitemid 26299290)
23. Kurachi K, Kurachi S. Molecular mechanisms of age-related regulation of genes. J Thromb Haemost 2005; 3:909-914. (Pubitemid 41632818)